Transient global amnesia as the first symptom o/f primary antiphospholipid syndrome: A case report

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 275-280

  Zardi, Enrico Maria ^a   Zardi, D M ^b   Lazarevic, Z ^c   Santucci, S ^b   D'Errico, F ^d   Carbone, A ^d   Gonnella, C ^d   Afeltra, A ^a   Tonioni, S ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME FORO ITALICO   (Italy)

^d Cardiology Division   (Italy)

Author keywords

Duplex Doppler ultrasonography; Multiple arterial occlusive disease; Primary antiphospholipid syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CONTRAST MEDIUM; ENOXAPARIN; INSULIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; ISCHEMIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; TRANSIENT GLOBAL AMNESIA; VERTEBRAL ARTERY STENOSIS; COLOR DOPPLER FLOWMETRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; SYMPTOMATOLOGY;

EID: 84861469145     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500131     Document Type: Article

References (21)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
2. Cervera R, Khamashta MA, Shoenfeld Y, et al; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009; 68:1428-32.
3. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8:998-1005.
4. Vlachoyiannopoulos PG, Routsias JG. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun 2010; 35:248-55.
5. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101:1827-32. (Pubitemid 36237580)
6. Tufano A, Guida A, Di Minno MN, De Gregorio AM, Cerbone AM, Di Minno G. Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention. Nutr Metab Cardiovasc Dis 2010; 20:217-23.
7. Farooqui SZ, Thong BY, Teoh SC. Neuroretinitis as an initial presentation of lupus-like illness with antiphospholipid syndrome. Lupus 2010; 19:1662-4.
8. Rinne T, Bronstein AM, Rudge P, Gresty MA, Luxon LM. Bilateral loss of vestibular function: clinical findings in 53 patients. J Neurol 1998; 245:314-21. (Pubitemid 28286795)
9. Hughes GRV Migraine, memory loss, and "multiple sclerosis". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J 2003; 79:81-3. (Pubitemid 36286620)
10. Manna R, Ricci V, Curigliano V, et al. Psychiatric manifestations as a primary symptom in antiphospholipid syndrome. Int J Immunopathol Pharmacol 2006; 19:915-7. (Pubitemid 46145054)
11. Rodrigues CEM, Carvalho JF, Shoenfeld Y. Eur J Clin Invest 2010; 40:350-9.
12. Winbeck K, Etgen T, von Einsiedel HG, Röttinger M, Sander D. DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. J Neurol Neurosurg Psychiatry 2005; 76:438-41. (Pubitemid 40299143)
13. Ozen S, Pistorio A, Lusan SM, et al.; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch Schonlein purpura, childood polyarteritis nodosa, childood Wegener granulomatosis and childood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010; 69:798-806.
14. Sharma S, Sharma P, Baltaro R, Hurley J. Systemic vasculitis. Am Fam Physician 2011; 83:556-65.
15. Montalban J, Arboix A, Staub H, Barquinero J, Marti-Vilalta J, Codina A, Hughes GR. Transient global amnesia and antiphospholipid antibodies. Clin Exp Rheumatol 1989; 7:85-7.
16. Cervera R, Piette JC, Font J, Khamashta MA, et al.; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-27. (Pubitemid 34303815)
17. Ortego-Centeno N, Callejas-Rubio J, Fernandez MG, Camello MG. Transient global amnesia in a patient with high and persistent level of antiphospholipid antibodies. Clin Rheumatol 2006; 25:407-8.
18. Plastiras SC, Tzelepis GE, Kelekis NL, Kelekis NL, Vlachoyiannopoulos PG. Catastrophic antiphospholipid syndrome with heart involvement: diagnostic utility of the cardiac MRI. Int J Cardiol 2007; 116:e29-31. (Pubitemid 46227631)
19. Cervera R. Bucciarelli S, Plasín MA, et al.; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry. J Autoimmun 2009; 32(3-4):240-5.
20. Grzybczak R, Undas A, Rostoff P, Gackowski A, Czubek U, Stopyra K, Piwowarska W. Life-threatening cardiac manifestations of primary antiphospholipid syndrome. Heart Vessels 2010; 25:267-9.
21. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome. A Systematic Review. JAMA 2006; 295:1050-7.